Quince Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $168 | $0 | $0 | $36 |
Gross Profit | 84 | -44 | -40 | |
EBITDA | -10,093 | -8,460 | -8,798 | -8,633 |
EBIT | -10,109 | -8,546 | -8,842 | -8,673 |
Net Income | -12,458 | -5,492 | -27,729 | -11,149 |
Net Change In Cash | 168 | 0 | 0 | 36 |
Free Cash Flow | -7,685 | -7,306 | -8,778 | -8,392 |
Cash | 6,212 | 2,675 | 7,890 | 21,813 |
Basic Shares | 43,262 | 43,164 | 43,096 | 43,010 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -322 | -175 | -344 | |
EBITDA | -57,285 | -31,260 | -52,015 | -89,974 |
EBIT | -31,582 | -52,190 | -90,318 | |
Net Income | -56,828 | -31,385 | -51,660 | -89,325 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -25,329 | |||
Free Cash Flow | -32,161 | -18,452 | -44,171 | -63,112 |
Cash | 6,212 | 20,752 | 44,579 | 69,724 |
Basic Shares | 43,262 | 37,237 | 33,496 | 29,718 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.28 |
2024-09-30 | -$0.12 |
2024-06-30 | -$0.64 |
2024-03-31 | -$0.21 |
